NEO

Abaxx Prepares Exchange Opening Sequence and Final Notices

Retrieved on: 
Monday, March 11, 2024

TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, announces the initiation of the final exchange trading launch sequence for Abaxx Exchange and Clearinghouse to open the market in each of its commodity futures contracts.

Key Points: 
  • TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, announces the initiation of the final exchange trading launch sequence for Abaxx Exchange and Clearinghouse to open the market in each of its commodity futures contracts.
  • Abaxx Exchange and Abaxx Clearing will request approval from their respective Boards of Directors to provide final notices to open Abaxx markets pending the near-term finalization of a third clearing member application approval.
  • Pending final notices, Abaxx Exchange and Abaxx Clearing will open with three approved clearing members, while additional clearing firms onboard through these clearing members or via applications as direct members of Abaxx Clearing.
  • Barring any unanticipated regulatory concerns in the final notice period, Abaxx Exchange and Abaxx Clearing will be operational and markets open.

DeFi Technologies Provides Monthly Corporate Update: Subsidiary Valour Scales to Record C$699.5 Million in Assets Under Management Up 40.7% from Previous Month

Retrieved on: 
Monday, March 4, 2024

Exceptional Market Activity and Growth: February showcased robust market activities for Valour, with a reported total turnover of approximately C$148.36 million and substantial total inflows of C$16.62 million.

Key Points: 
  • Exceptional Market Activity and Growth: February showcased robust market activities for Valour, with a reported total turnover of approximately C$148.36 million and substantial total inflows of C$16.62 million.
  • The AUM for the Valour Solana ETP has seen considerable growth, now standing at C$290.3 million, which also reflects positively on the company-wide AUM.
  • A particular highlight of February was Valour Solana ETP, which saw net inflows of C$4.89 million, increasing its AUM to C$290.3 million.
  • We are committed to continuing this trajectory and enhancing our digital asset offerings," said Olivier Roussy Newton, CEO of DeFi Technologies.

DeFi Technologies Inc. Announces Record AUM of C$590 Million, Launch of Valour Inc.’s Ripple (XRP) and Binance (BNB) ETPs

Retrieved on: 
Thursday, February 22, 2024

Launch of XRP and BNB ETPs: Valour has introduced Ripple (“XRP”) and Binance (“BNB”) Exchange Traded Products on Nordic Growth Market (“NGM”) exchange expanding its range of digital asset investment products.

Key Points: 
  • Launch of XRP and BNB ETPs: Valour has introduced Ripple (“XRP”) and Binance (“BNB”) Exchange Traded Products on Nordic Growth Market (“NGM”) exchange expanding its range of digital asset investment products.
  • Additionally, Valour has launched Ripple (“XRP”) and Binance (“BNB”) ETPs on the Nordic Growth Market (“NGM”) exchange.
  • Additionally, Valour has launched Ripple (XRP) and Binance (BNB) ETPs on the NGM exchange.
  • "The introduction of the Ripple (XRP) and Binance (BNB) ETPs by Valour marks a significant expansion of our product offerings," said Olivier Roussy Newton, CEO of DeFi Technologies.

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference

Retrieved on: 
Friday, March 1, 2024

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts.

Key Points: 
  • NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts.
  • Members of NeoGenomics’ management team will participate in a fireside chat on Tuesday, March 5th at 9:10 a.m.
  • ET.
  • A live and archived audio webcast of the presentation will be available on the “News, Events, and Webcasts” tab via the Investor Relations section of the Company’s website at ir.neogenomics.com .

The Cannabist Company Highlights Product Innovation with Launch of Unique Fast-Acting and Longer-Lasting Layered Edibles

Retrieved on: 
Thursday, February 22, 2024

The dual-action, bi-layered gummies are a cutting-edge fusion offering a swift onset with lasting effects.

Key Points: 
  • The dual-action, bi-layered gummies are a cutting-edge fusion offering a swift onset with lasting effects.
  • “This is a true example of our commitment to product innovation – bringing our customers one of the most creative edibles to date.
  • “This revolutionary edible is also an amazing representation of everything that the Hedy brand stands for – fun, inviting, and flavorful.
  • Hedy was launched by The Cannabist Company in the fall of 2022 and is currently available in eleven markets.

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Tuesday, February 20, 2024

NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 results for the period ended December 31, 2023.

Key Points: 
  • NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 results for the period ended December 31, 2023.
  • Consolidated gross profit for the fourth quarter of 2023 was $67.6 million, an increase of 18.9% compared to the fourth quarter of 2022.
  • Operating expenses for the fourth quarter of 2023 were $86 million, an increase of $3 million, or 4%, compared to the fourth quarter of 2022.
  • Net loss for the quarter was $14 million compared to net loss of $23 million for the fourth quarter of 2022.

DeFi Technologies Announces Inaugural Bitcoin Investor Day Hosted by Subsidiary Reflexivity Research

Retrieved on: 
Thursday, March 7, 2024

Inaugural Bitcoin Investor Day: DeFi Technologies' subsidiary Reflexivity Research is hosting its inaugural Bitcoin Investor Day on March 22nd, 2024, in New York City, aimed at bridging the power of traditional finance with the innovation of Bitcoin.

Key Points: 
  • Inaugural Bitcoin Investor Day: DeFi Technologies' subsidiary Reflexivity Research is hosting its inaugural Bitcoin Investor Day on March 22nd, 2024, in New York City, aimed at bridging the power of traditional finance with the innovation of Bitcoin.
  • TORONTO, March 7, 2024 /PRNewswire/ - DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (NEO: DEFI) (GR: RB9) (OTC: DEFTF), a crypto native technology company that pioneers the convergence of traditional capital markets with the world of decentralised finance ("DeFi"), is pleased to announce that its subsidiary, Reflexivity Research, will be hosting its inaugural Bitcoin Investor Day.
  • The Bitcoin Investor Day, orchestrated by Reflexivity Research, aims to assemble hundreds of institutional investors, capital allocators, and forward-thinking entrepreneurs.
  • DeFi Technologies and Reflexivity Research would like to express their sincere thanks to the event's sponsors—Copper, Arch, Amberdata, Valour, Dream Startup Job, and Eden—for their steadfast support and significant contributions, ensuring the Bitcoin Investor Day is poised for success.

DeFi Technologies Provides Monthly Corporate Update: Subsidiary Valour Scales to Record C$699.5 Million in Assets Under Management Up 40.7% from Previous Month

Retrieved on: 
Monday, March 4, 2024

Exceptional Market Activity and Growth: February showcased robust market activities for Valour, with a reported total turnover of approximately C$148.36 million and substantial total inflows of C$16.62 million.

Key Points: 
  • Exceptional Market Activity and Growth: February showcased robust market activities for Valour, with a reported total turnover of approximately C$148.36 million and substantial total inflows of C$16.62 million.
  • The AUM for the Valour Solana ETP has seen considerable growth, now standing at C$290.3 million, which also reflects positively on the company-wide AUM.
  • A particular highlight of February was Valour Solana ETP, which saw net inflows of C$4.89 million, increasing its AUM to C$290.3 million.
  • We are committed to continuing this trajectory and enhancing our digital asset offerings," said Olivier Roussy Newton, CEO of DeFi Technologies.

Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer

Retrieved on: 
Friday, February 23, 2024

DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").

Key Points: 
  • DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").
  • This follows Nirup Krishnamurthy's resignation as CEO and as a member of the Board of Directors ("Board"), effective February 20, 2024, due to personal reasons.
  • Mr. Hoffmaster, who joined the Company in January 2023, brings over 30 years of executive experience in finance and operations for both public and private companies.
  • Prior to New Seasons Market, Forrest held leadership positions with other leading grocers including Whole Foods Market and H-E-B.

Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer

Retrieved on: 
Friday, February 23, 2024

DENVER, Feb. 23, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").

Key Points: 
  • DENVER, Feb. 23, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").
  • This follows Nirup Krishnamurthy's resignation as CEO and as a member of the Board of Directors ("Board"), effective February 20, 2024, due to personal reasons.
  • Mr. Hoffmaster, who joined the Company in January 2023, brings over 30 years of executive experience in finance and operations for both public and private companies.
  • Prior to New Seasons Market, Forrest held leadership positions with other leading grocers including Whole Foods Market and H-E-B.